5 things to watch on the ASX 200 on Tuesday

A better day of trade is expected for Aussie investors today.

Smiling man with phone in wheelchair watching stocks and trends on computer

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week in a disappointing fashion. The benchmark index sank 1.2% to 8,191.9 points.

Will the market be able to bounce back from this on Tuesday? Here are five things to watch:

ASX 200 expected to rebound

The Australian share market is expected to rebound slightly on Tuesday after a mixed start to the week in the United States. According to the latest SPI futures, the ASX 200 is poised to open the day 23 points or 0.3% higher. In late trade on Wall Street, the Dow Jones is up 0.6%, but the S&P 500 is down 0.15% and the Nasdaq is 0.8% lower.

Buy the Newmont shares

The team at Goldman Sachs thinks investors should be buying Newmont Corporation (ASX: NEM) shares. This morning, the broker has initiated coverage on the gold miner's shares with a buy rating and $76.20 price target. This implies potential upside of almost 20% over the next 12 months. It said: "Newmont has one of the strongest EBITDA growth outlooks amongst our Australian gold coverage on a medium-term view on the back of production improvements across new and existing projects, further supported by gold pricing strength."

Oil prices jump

It could be a great session for ASX 200 energy shares Santos Ltd (ASX: STO) and Karoon Energy Ltd (ASX: KAR) on Tuesday after oil prices jumped overnight. According to Bloomberg, the WTI crude oil price is up 3% to US$78.88 a barrel and the Brent crude oil price is up 1.5% to US$80.98 a barrel. This was driven by expectations that Chinese and Indian supplies could be hit by Russian sanctions.

Telix beats guidance

Telix Pharmaceuticals Ltd (ASX: TLX) shares will be on watch today after the ASX 200 biotech stock beat its guidance for FY 2024. After the market close, the company revealed that FY 2024 unaudited revenue is approximately US$517 million (A$783 million). This exceeds its previously stated guidance of US$490 million to US$510 million, representing a 55% increase over FY 2023.

Gold price falls

ASX 200 gold miners including Bellevue Gold Ltd (ASX: BGL) and Regis Resources Limited (ASX: RRL) could have a poor session on Tuesday after the gold price tumbled overnight. According to CNBC, the gold futures price is down 1.3% to US$2,678.6 an ounce. A stronger US dollar put pressure on the precious metal.

Motley Fool contributor James Mickleboro has positions in Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

man with dog on his lap looking at his phone in his home.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Two workers at an oil rig discuss operations.
Broker Notes

Should you buy Santos, Beach Energy or Woodside shares? Here's Macquarie's top pick

Macquarie has released its new share price expectations for Santos, Beach Energy and Woodside shares.

Read more »

A green fully charged battery symbol surrounded by green charge lights representing the surging Vulcan share price today
Share Market News

Up 300% in 6 months! This soaring ASX lithium stock just took a major step to production

Marching forward.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Macquarie says this top ASX tech stock could rise 15%

Let's see what the broker is saying about this stock.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »